Our Team

Mission-led, expert-driven.

Neurobiology, clinical research, regulatory strategy, and technology — the people building Hope Neuron are united by one goal: reversing neurodegeneration at its immune root.

Ronald H. Lane, PhD Ronald H. Lane, PhD Founder & Executive Chairman

Neurobiologist and inventor of the SELtx™ platform.

LinkedIn
Yansheng Du, PhD Yansheng Du, PhD Head of Pre-Clinical Transgenic Research

Professor of Neurology at Indiana University School of Medicine, overseeing pre-clinical transgenic research.

LinkedIn
Mark Forney Mark Forney Vice President Business Development

Advisor on securities strategy and capital formation.

LinkedIn
Karina Fedasz Karina Fedasz Interim CFO

Leads regulatory and registration efforts.

LinkedIn
John Louf John Louf Chief Technology Officer

Leads development of AI systems that accelerate neurological research and power Hope Neuron's data-driven platform.

Caleb Marsh Caleb Marsh Chief Communications Officer

Leads communications and marketing efforts.

LinkedIn

Want to work with us — or fund the mission?

Get in touch